Research | UW–Madison

University of Wisconsin–Madison

Jillian Kyzer, a medicinal chemist and staff scientist in the School of Pharmacy, synthesizes a chemical reaction as part of her work in the Wenthur Lab, which explores how psychedelics can improve mental health disorders. The investment from WARF will help fund research to produce foundational data around brain health. PHOTO: SHARON VANORNY

$27M WARF investment fuels UW–Madison’s next frontiers in resear

$27M WARF investment fuels UW–Madison’s next frontiers in research

The U.S. National Science Foundation renews NSF IceCube operation and maintenance contract

Fall Research Competition accepting proposals from Aug. 17 to Sept. 4.

42 faculty receive 2026-27 WARF Named Professorship, Kellett Fellowships and H.I. Romnes Awards

Three finalists selected for Director of Research Development: Presentations began Aug. 3, Next presentations are Aug. 18 and 21. Feedback is due Aug. 27

UW Distinguished Research Fellows Program is in full swing

Read WARF story

Discover Research

UW Research at a Glance

5th
in nation for volume of research
$1.93B
spent on research
19
VCR research and service centers

IceCube at South Pole

Research Innovation at UW–Madison Overview

SSEC rooftop

Learn about VCR research centers

Biotech Bucky

Industry Partnerships

Apply for research funding and grants

n the late 1950s, Kay Emerson became the first person in Wisconsin to be successfully treated for phenylketonuria (PKU), a rare metabolic condition that can cause severe intellectual and developmental disability if left untreated. She was treated by Harry Waisman, MD, PhD, who was a renowned PKU researcher and physician and who the Waisman Center is named after. He advocated to add PKU to the Newborn Screening Panel in Wisconsin.

Centers in the news

New Faculty